Skip to main content
Caplight Logo









Eyebot

Eyebot

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.eyebot.co/

Last Round

Series A

Aug 26, 2025

Total Funding Raised

$28M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Eyebot is a healthcare technology company that develops automated, self-serve vision testing kiosks designed to provide accessible eye prescriptions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Retail Technology, Telemedicine, Computer Vision

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Hardware + Subscription, Freemium

AI Layer

Application

Keywords

vision testing kioskautomated eye examtele-optometryglasses prescriptionretail health kioskdigital eye examvision screeningautorefractortelemedicineeye care technologyB2B2CAI-powered eye examremote eye care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eyebot Comparables

Compare Eyebot with similar companies based on industry and business-model similarity.

Eyebot comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GlobeChek
78%
Visibly
78%
DigitalOptometrics
78%

Eyebot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 26, 2025
SeedJun 6, 2024
Pre SeedSep 29, 2022

Key People

Founding team and executive leadership

Matthias Hofmann

Co-founder & CEO

Founding Team

Eyebot Investors

Notable investors and investment history

Eyebot investors
InvestorRounds
AlleyCorpSeries A, Seed
Global VillageSeed, Series A
Ravelin CapitalSeed
General CatalystSeries A
Village GlobalSeed, Pre Seed, Series A
Humba VenturesSeed, Series A
Spacecadet VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2026

    Automated vision testing technology pilot program launching December 1st, 2026.

  • Jan 6, 2026

    Introduced an end-to-end optical experience with The Framery.

Eyebot Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Eyebot Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Eyebot's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range39
Year Founded2021
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?